Innovative Industrial Properties (NYSE: IIPR) is the cannabis landlord graduating from its stress test: the PharmaCann default saga is resolved (properties recovered, judgments won, most already re-leased), the $1.90 quarterly dividend was held throughout, and the balance sheet remains among the least levered in all REITs. Our grade caps it anyway, and the reason is the methodology working.
| Innovative Industrial Properties (IIPR) Snapshot | |
|---|---|
| Share Price (delayed) | $63.72 -0.11% |
| Market Cap | $1.8B |
| Annualized Dividend | $7.60 (Quarterly) |
| Dividend Yield | 11.93% |
| AFFO Payout Ratio | 101% |
| Sector | Industrial ยท Regulated Cannabis |
Market data updates automatically several times daily. Last price refresh: Jul 14, 2026.
Business Model and the Stress Test
IIPR built the sale-leaseback market for regulated cannabis cultivation, and the sector’s brutal downturn ran defaults through its rent roll: PharmaCann, TILT, and 4Front cut revenue roughly 13% year over year, with Q4 2025 AFFO at $1.88 per share. The response has been genuinely strong: the March 2026 PharmaCann settlement recovered the properties with monetary judgments, new leases keep signing (hundreds of thousands of square feet across Michigan, Massachusetts, Illinois, California), and debt sits near 11% of gross assets, fortress territory.
Dividend Reality and the Grade Cap
Management held the $1.90 dividend against $1.88 of quarterly AFFO: a payout above 100%, and our published methodology caps any REIT paying above 100% of AFFO at the C band, no exceptions for good balance sheets. Re-tenanting could restore coverage within quarters; until it does, the cap holds.
The Honest Risk Section
Tenant credit is the permanent condition: cannabis operators live without bankruptcy-court access or normal banking, so defaults resolve slowly and colorfully. Federal policy is the binary nobody can time, and re-leasing specialized cultivation space takes quarters, not weeks. The fortress balance sheet buys time; it doesn’t change the tenant base.
Frequently Asked Questions
Why is IIPR graded C with such low debt?
The dividend exceeds 100% of current AFFO ($1.90 paid vs $1.88 earned per quarter), which triggers our methodology’s automatic C-band cap regardless of balance sheet strength.
Is the PharmaCann situation resolved?
Yes: a March 2026 settlement returned the properties with monetary judgments to IIPR, and most former PharmaCann facilities have been re-leased to new operators.
Analysis based on Q4 2025 results and March 2026 settlement disclosures. Live market data updates automatically. Independent research, not investment advice.